FDA Investigator Jorge L Lajara

Jorge L Lajara has inspections in 3 countries as of 21 Mar 2024. Jorge L Lajara has collaborated with a combinined 3548 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
21 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Argentina, Spain
Adalberto Cajigas, Adaliz Santaliz Cruz, Agnes M Santori, Alan A Rivera, Alexander B Anderson, Alicia M Mozzachio, Alonso, Ana M Rivera, Andrea George, PhD, Andrea J Schmidt, Angela F Orozco, Angelica M Hernandez, Annette Melendez, Ariel Cruz Figueroa, Arlene M Badillo, Ashley N Queen, PhD, Beira Montalvo, Brenda Rivera, Calvin B Koerner, Candido Torres, Carlos A Medina, Carpios, Cassandra L Abellard, CDR Ileana Barreto Pettit, Cheryl A Clausen, Christopher Downey, PhD, Clara E Santiago, Colleen F Hoyt, Colleen Thomas, PhD, David J Leray, Dayna I Martinez, Dell S Moller, Dennis Cantellops Paite, Donald C Obenhuber, PhD, Donna L Lagarde, Dov Pluznik, PhD, Dr. Carmelo Rosa, Eddie A Santini, Edwin Martinez, Eliezar Ramos, Enrique Galan, Eric R Holm, Erika V Butler, Eva I Merced Medina, Frances L Dejesus, Frank Flores, Frederick L Fricke, Garcial, German Rivera, Hector Espinet, Hector J Colon Torres, Hristu B Chepa, Ileana Pettit, Iraida Ortiz, Israel Santiago, OCM, Ivis Lnegron Torres, Ivonne A Vicente, Jaime E Pares, Javier O Vega, Jennifer Lalama, Jennifer M Menendez, Jerri Baker, Joan Cantellops Figueroa, Joan M Cantellops Figueroa, Joanne E King, Joe X Phillips, Jorge E Martinez, Jorge L Gonzalez, Jorge L Guadalupe, Jose A Cruz, Jose A Moreno, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose Fpedrode Jesus, Jose M Cayuela, Jose Melendez, Jose Perez Soto, Jose R Lopez, Jose Rflores Veguilla, Jose Velez, Juan Rjimenez Garcia, Karl D Hezel, Katherine Vargas Serrano, Keishla M Arroyo Lopez, Laiza V Garcia, Laura E Garcia, Laurimer Kuilan, Laurimer Kuilan Torres, LCDR Cornelius Brown, III, Leslie A Mendoza, Libia M Lugo, Lisa M Lopez, Lissette Paiz, Lizaida E Rodriguez, Loreily Figueroa, Loreily Figueroa Agrinsoni, Lourdes Andujar, LT Luis O Rodriguez, LT Rafael Gonzalez, LT Richard A Lyght, Luis A Carrion, Luis G Rivera, Luz N Riveradecruz, Margarita Santiago, Maria A Medina, Maria A Ruttell, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Marianela Aponte, Marianela Aponte Cruz, Maribel V Juarbe, Maricelys Mercado, Maridalia Torres, Maridalia Torres Irizarry, Marie A Fadden, Marie T Falcone, Marilyn Santiago, Marinee Flores Marrero, Marta E Gonzalez, Marybeth Willis, Maxwell Van Tassell, PhD, Medina, Mendoza, Merced, Michael A Charles, Michael L Casner, Michael S Berg, Michael Shanks, MS, Michelle Y Clark Stuart, Miguel A Martinez, Miguel G Manzano, Milva E Melendez, Milva Emelendez Perales, Minerva Rogers, Monica Cburgos Garcia, Moraima J Ramos Valle, Myriam M Sosa, Nancy Rosado, Neisa M Alonso, Nicholas Obiri, PhD, Nikolay Spiridonov, Noreen Muniz, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Pablo Feliciano, Patricia Fhughes Troost, Patrick C Klotzbuecher, Paul Z Balcer, Paula A Trost, Prabhu P Raju, Rachel A Gomez, Rafael E Cruz, Rafael Nevarez, Rafael Nevarez Nieves, Ramesh Potla, PhD, Ramon A Hernandez, Raquel Gonzalez Rivera, Raymond A Lyn, Jr, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Riley C Myers, PhD, Rina Bhikha, Robert D Ogan, Robert Darius, Robert Q Jennings, Robert W Jennings, Ronald Ifraimov, Rosa J Motta, Roy R Rinc, Rupa Pradhan, Sandra Carpio, Shelly A Rios Laluz, Sixto M Mercado Rios, Sixto Mercado Rios, Sonia M Monges, State Agency, Stephen E Langille, Steven B Barber, Steven C Madzo, Steven Fong, MS, PhD, Thomas J Arista, Timothy Wadkin, PhD, Victor S Pacheco, Vilmary Negron Rodriguez, Viviana Matta, Wanda J Torres, Wendy G Tan, PhD, Youmin Wang, Zachary L Stamm, Zhihao Qiu (Peter), PhD, Zhong Li, PhD, Zuleika A Pineiro Vargas

Jorge L Lajara's Documents

Publish Date Document Type Title
December, 2003 EIR Llorens Pharmaceutical Corp - EIR, 2003-12-17
September, 2006 FDA 483 Omega & Delta Co. Inc. - Form 483, 2006-09-29
August, 2009 FDA 483 AV Industries, Inc. - Form 483, 2009-08-13
November, 2003 EIR Re-Por Laboratories - EIR, 2003-11-28
August, 2009 FDA 483 Pfizer Pharmaceuticals LLC-Piperacillin - Form 483, 2009-08-07
September, 2003 EIR CEPH International Corporation - EIR, 2003-09-26
June, 2010 FDA 483 Ortho Biologics LLC - Form 483, 2010-06-25
June, 2008 FDA 483 APP Pharmaceuticals, LLC. - Form 483, 2008-06-19
November, 2003 EIR Portal Pharmaceutical - EIR, 2003-11-21
July, 2007 FDA 483 Alberto Culver (P.R.), Inc. - Form 483, 2007-07-31
September, 2008 FDA 483 Teva Puerto Rico LLC - Form 483, 2008-09-15
October, 2007 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2007-10-29
July, 2003 EIR Lopez Gonzalez Santana Corporation - EIR, 2003-07-23
August, 2008 FDA 483 McNeil Healthcare LLC. - Form 483, 2008-08-06
June, 2006 FDA 483 Pfizer Pharmaceuticals LLC-Piperacillin - Form 483, 2006-06-29
November, 2012 EIR Lanza & Sons, Inc. - EIR, 2012-11-30
May, 2004 EIR Cardinal Health Manufacturing Services B.V. - EIR, 2004-05-27
July, 2003 FDA 483 Lopez Gonzalez Santana Corporation - Form 483, 2003-07-23
December, 2005 FDA 483 Teva Puerto Rico LLC - Form 483, 2005-12-02
September, 2003 FDA 483 CEPH International Corporation - Form 483, 2003-09-26
November, 2004 EIR Smithkline Beecham (Cork) Inc. - EIR, 2004-11-05
December, 2003 EIR Efficient Laboratories, Inc. - EIR, 2003-12-09
May, 2004 FDA 483 Cardinal Health Manufacturing Services B.V. - Form 483, 2004-06-22
September, 2006 FDA 483 Syntex Puerto Rico, Inc. - Form 483, 2006-09-28
April, 2019 FDA 483 BMF, Inc. - Form 483, 2019-04-17
March, 2014 EIR Deliz Pharmaceutical Corp. - EIR, 2014-03-06
March, 2006 FDA 483 Biovail Laboratories International SRL - Form 483, 2006-03-17
June, 2007 FDA 483 Creative Medical Corp. - Form 483, 2007-06-11
August, 2008 EIR McNeil Healthcare LLC. - EIR, 2008-08-06
February, 2017 EIR Lopez Gonzalez Santana Corporation - EIR, 2017-02-10
March, 2007 FDA 483 Bristol Myers Squibb Manufacturing, Co. - Form 483, 2007-03-22
April, 2019 FDA 483 Response BMF, Inc. - Form 483R, 2019-05-03
March, 2010 FDA 483 Auro PR Inc. - Form 483, 2010-03-29
November, 2004 FDA 483 Smithkline Beecham (Cork) Inc. - Form 483, 2004-11-05
September, 2006 FDA 483 Legacy Pharmaceuticals Puerto Rico, LLC - Form 483, 2006-09-28
June, 2009 FDA 483 Wyeth Parenterals Divison of Wyeth Holdings Corp. - Form 483, 2009-06-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more